PRCT β€” PROCEPT BIOROBOTICS CORP

Ownership history in ArrowMark Colorado Holdings LLC  Β·  7 quarters on record

AI Ownership Summary

ArrowMark Colorado Holdings LLC reported PROCEPT BIOROBOTICS CORP (PRCT) in 7 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.93% in 2025 Q4. The latest visible filing shows PRCT at 0.93% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this PRCT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was ArrowMark Colorado Holdings LLC's position in PROCEPT BIOROBOTICS CORP, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

PRCT was reported at 0.93% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.93% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How ArrowMark Colorado Holdings LLC held PRCT β€” position size vs. price
% of Fund (quarterly)    PRCT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 6 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED 1,349,831 +221,543 +19.6% 0.93% $42.5M 2026-02-14 (Est.) $27.79
2025 Q3 ADDED 1,128,288 +786,094 +229.7% 0.75% $40.3M 2025-11-14 $29.69
2025 Q2 ADDED 342,194 +272,723 +392.6% 0.35% $19.7M 2025-08-14 $40.12
2024 Q2 REDUCED 69,471 -48,493 -41.1% 0.05% $4.2M 2024-08-14 $64.56
2024 Q1 REDUCED 117,964 -18,736 -13.7% 0.07% $5.8M 2024-05-15 $69.19
2023 Q4 ADDED 136,700 +25,086 +22.5% 0.06% $5.7M 2024-02-14 $50.38
1 older quarter hidden  β€”  Sign in free or upgrade to Premium to see full history

FAQ About ArrowMark Colorado Holdings LLC and PRCT

These are the practical questions this page is built to answer before you even open the full history table.

How long has ArrowMark Colorado Holdings LLC reported owning PRCT?

ArrowMark Colorado Holdings LLC reported PRCT across 6 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported PRCT position in ArrowMark Colorado Holdings LLC's portfolio?

The largest reported portfolio weight for PRCT was 0.93% in 2025 Q4.

What is the latest reported PRCT position on this page?

The most recent filing on this page is 2025 Q4, when ArrowMark Colorado Holdings LLC reported 1,349,831 shares, equal to 0.93% of portfolio, with an estimated market value of $42.5M.

What does the chart on this PRCT ownership page compare?

The chart compares ArrowMark Colorado Holdings LLC's quarterly PRCT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to ArrowMark Colorado Holdings LLC Holdings